BMC Cancer · 2018 · 32 citations · 32 references
To conclude, ERK is an effective negative regulator of STAT1 signaling in ESCC, by promoting its proteasome degradation and decreasing IFNγ production. Our data further supports that targeting ERK and/or STAT1 may be useful for treating ESCC.
32
Regulation of Interferon-γ-Activated STAT1 by the Ubiquitin-Proteasome Pathway
Tae Kook Kim, Tom Maniatis · Science · 1996 · 404 citations
Chen Wu, Peter Kraft, Kan Zhai et al. · Nature Genetics · 2012 · 271 citations
Genome-wide Association Study, Esophageal Cancer, Gene-environment Interactions +8